BrightSpring Health Services, Inc. BTSG
56.59
0.57
1.02%
as of 25 Sep
- Market cap
- $11.1B
- P/E
- 31.6×
Follow BTSG
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 19.31% | 16.90% | 10.82% | 7.55% |
+8 more TTM periods Free account |
|
| 6.14% | 5.14% | 3.09% | 2.19% | ||
ROIC |
7.56% | 6.35% | 4.28% | 3.61% | |
Return on Tangible Assets |
32.44% | 23.08% | 15.26% | 9.22% | |
Average Days of Receivables |
28.94 | 29.78 | 27.98 | 30.54 | |
Free Cash Flow per Share |
1.95 | 2.01 | 1.95 | 1.36 | |
Free Cash Flow |
402.35 | 412.12 | 394.69 | 276.09 | |
Capital Expenditures |
(104.00) | (99.40) | (95.48) | (73.13) | |
Piotroski F-Score |
7.00 | 7.00 | 7.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
10.54% | 9.51% | 10.93% | 7.78% | |
Accounts Receivable Turnover |
13.61 | 13.07 | 13.64 | 11.88 | |
Accounts Payable Turnover |
12.25 | 12.23 | 10.64 | 12.27 | |
Inventory Turnover |
20.98 | 21.91 | 15.70 | 19.08 | |
Average Days of Payables |
31.62 | 33.24 | 39.02 | 32.67 | |
Days of Inventory on Hand |
16.67 | 17.06 | 26.12 | 21.88 | |
Tax Rate |
(0.16) | (0.20) | (0.24) | (0.23) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
9.27% | 9.49% | 9.47% | 9.92% | |
Share Based Compensation of Revenue |
0.38% | 0.43% | 0.54% | 0.58% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.38 | 1.65 | 2.57 | 2.69 | |
Depreciation/Fixed assets |
0.81 | 0.85 | 0.86 | 1.09 | |
Capex/Depreciation |
(0.60) | (0.58) | (0.54) | (0.38) | |
Revenue per Share |
69.75 | 66.66 | 63.74 | 59.50 | |
Operating CF per Share |
2.46 | 2.50 | 2.42 | 1.72 | |
Capex per Share |
(0.50) | (0.49) | (0.47) | (0.36) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
2.55% | 2.27% | 1.48% | 1.07% |
Columns are period end dates